Literature DB >> 20421405

Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.

Ana Alastruey-Izquierdo1, Isabel Cuesta, Grit Walther, Manuel Cuenca-Estrella, Juan Luis Rodriguez-Tudela.   

Abstract

Forty-four isolates belonging to human pathogenic species of Lichtheimia were tested against nine antifungal agents by using the EUCAST methodology. No remarkable differences were found between the clinical species, although L. ramosa showed slightly higher MICs for all drugs. Amphotericin B was the most active drug. Among azole drugs, posaconazole had the best activity in vitro and voriconazole was inactive. Echinocandins showed activity for some isolates, suggesting a potential role in combination therapy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20421405      PMCID： PMC2897292          DOI： 10.1128/AAC.01270-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans.

Authors:  E Petrikkou; J L Rodríguez-Tudela; M Cuenca-Estrella; A Gómez; A Molleja; E Mellado
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi.

Authors:  A Aberkane; M Cuenca-Estrella; A Gomez-Lopez; E Petrikkou; E Mellado; A Monzón; J L Rodriguez-Tudela
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

3.  Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi.

Authors:  J L Rodriguez-Tudela; Erja Chryssanthou; Evangelia Petrikkou; Juan Mosquera; David W Denning; Manuel Cuenca-Estrella
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 4.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

5.  In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

6.  In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method.

Authors:  Jagpal Singh; Dagmar Rimek; Reinhard Kappe
Journal:  Mycoses       Date:  2005-07       Impact factor: 4.377

7.  Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.

Authors:  Ana Alastruey-Izquierdo; Maria Victoria Castelli; Isabel Cuesta; Araceli Monzon; Manuel Cuenca-Estrella; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

8.  Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.

Authors:  M B Kurtz; I B Heath; J Marrinan; S Dreikorn; J Onishi; C Douglas
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

9.  Spectrum of zygomycete species identified in clinically significant specimens in the United States.

Authors:  E Alvarez; D A Sutton; J Cano; A W Fothergill; A Stchigel; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

10.  In vitro susceptibilities of zygomycetes to conventional and new antifungals.

Authors:  Eric Dannaoui; Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790
View more
  11 in total

1.  Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.

Authors:  Roxana G Vitale; G Sybren de Hoog; Patrick Schwarz; Eric Dannaoui; Shuwen Deng; Marie Machouart; Kerstin Voigt; Wendy W J van de Sande; Somayeh Dolatabadi; Jacques F Meis; Grit Walther
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization-time of flight analyzer-mediated mass spectrometry.

Authors:  Wieland Schrödl; Tilo Heydel; Volker U Schwartze; Kerstin Hoffmann; Anke Grosse-Herrenthey; Grit Walther; Ana Alastruey-Izquierdo; Juan Luis Rodriguez-Tudela; Philipp Olias; Ilse D Jacobsen; G Sybren de Hoog; Kerstin Voigt
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

3.  Pulmonary mucormycosis due to Lichtheimia ramosa in a patient with HIV infection.

Authors:  Murat Kutlu; Cağrı Ergin; Ferda Bir; Süleyha Hilmioğlu-Polat; Ramazan Gümral; Ceyda Necan; Ali Koçyiğit; Selda Sayın-Kutlu
Journal:  Mycopathologia       Date:  2014-06-13       Impact factor: 2.574

4.  Necrotizing fasciitis in neonate by Lichtheimia ramosa : A case study.

Authors:  Ashish William; Ravinder Kaur; Deepti Rawat; Neelam S S Kandir; Akanksha Sharma
Journal:  Access Microbiol       Date:  2022-03-09

5.  Gene expansion shapes genome architecture in the human pathogen Lichtheimia corymbifera: an evolutionary genomics analysis in the ancient terrestrial mucorales (Mucoromycotina).

Authors:  Volker U Schwartze; Sascha Winter; Ekaterina Shelest; Marina Marcet-Houben; Fabian Horn; Stefanie Wehner; Jörg Linde; Vito Valiante; Michael Sammeth; Konstantin Riege; Minou Nowrousian; Kerstin Kaerger; Ilse D Jacobsen; Manja Marz; Axel A Brakhage; Toni Gabaldón; Sebastian Böcker; Kerstin Voigt
Journal:  PLoS Genet       Date:  2014-08-14       Impact factor: 5.917

6.  In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles.

Authors:  Andrew M Borman; Mark Fraser; Zoe Patterson; Michael D Palmer; Elizabeth M Johnson
Journal:  J Fungi (Basel)       Date:  2021-04-02

Review 7.  MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis.

Authors:  Neelja Singhal; Manish Kumar; Pawan K Kanaujia; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2015-08-05       Impact factor: 5.640

8.  Lichtheimia ramosa: A Fatal Case of Mucormycosis.

Authors:  Cecilia Mouronte-Roibás; Virginia Leiro-Fernández; Maribel Botana-Rial; Cristina Ramos-Hernández; Guillermo Lago-Preciado; Concepción Fiaño-Valverde; Alberto Fernández-Villar
Journal:  Can Respir J       Date:  2016-03-29       Impact factor: 2.409

Review 9.  Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance.

Authors:  Felicia Adelina Stanford; Kerstin Voigt
Journal:  Genes (Basel)       Date:  2020-10-30       Impact factor: 4.096

10.  Hepatic failure and malnutrition as predisposing factors of cutaneous mucormycosis in a pediatric patient.

Authors:  Silvia Colman; Gustavo Giusiano; Carmen Colman; María de Los Ángeles Sosa; Florencia Rojas
Journal:  Med Mycol Case Rep       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.